Skip to main content
. 2015 Dec 9;5(12):e009764. doi: 10.1136/bmjopen-2015-009764

Table 4.

Treatment goals for medical regulation

Medication Treatment goals Intensification of treatment during standardisation Intensification of treatment at follow-ups
Antidiabetics HbA1c ≤48 mol/mol HbA1c >64 mmol/L or 5 mmol/mol increment HbA1c >58 mmol/L or 5 mmol/mol increment
Antihypertensive BP ≤130/80 mm Hg BP >150/95 mm Hg BP >140/85 mm Hg
Antilipids LDL ≤2.0 mmol/L
TG ≤5.0 mmol/L
LDL >2.0 mmol/L
TG >5.0 mmol/L
LDL >2.0 mmol/L
TG >5.0 mmol/L

The table shows treatment goals for the U-TURN intervention and intensification of treatment. If the treatment target is reached, the dose of the compound is halved at the following control time point (3 months later). In case of unchanged values or an additional drop, the compound is then discontinued.

BP, blood pressure; HbA1c, glycated haemoglobin; LDL, low-density lipoproteins; TG, triglycerides.